MAPT and Atrophy: During a 10-year follow-up, the rates of temporal lobe atrophy were accelerated in asymptomatic MAPT mutation carriers who were asymptomatic during follow-up, while accelerated atrophy rates in the temporal, parietal and frontal lobes were reported in MAPT mutation carriers who became symptomatic compared to non-carriers (23).